SCHEMBL19936626

SCHEMBL19936626

C1CN(C2C[C@@H]3C[C@@H]3C2)CCO1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2A13 Q16696 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.42
ALDH1A1 P00352 2/20 0.38
HPGD P15428 1/20 0.38
CA12 O43570 1/20 0.35
CA7 P43166 1/20 0.35
CA14 Q9ULX7 1/20 0.35
L3MBTL1 Q9Y468 3/20 0.33
KDM1A O60341 1/20 0.33
MAOB P27338 1/20 0.33
L3MBTL3 Q96JM7 1/20 0.33
DPP4 P27487 1/20 0.33
OPRL1 P41146 2/20 0.33
MGLL Q99685 1/20 0.32
KDM4E B2RXH2 1/20 0.31
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22180343 1.00 CYP2A13 (0.48) CYP2A13SMN1; SMN2ALDH1A1HPGDCA12
SCHEMBL22180112 1.00 CYP2A13 (0.48) CYP2A13SMN1; SMN2ALDH1A1HPGDCA12
SCHEMBL22179872 1.00 CYP2A13 (0.48) CYP2A13SMN1; SMN2ALDH1A1HPGDCA12
SCHEMBL22180327 0.91 CYP2A13 (0.42) CYP2A13SMN1; SMN2ALDH1A1HPGDCA12
SCHEMBL25148889 0.77 CYP2A13 (0.41) CYP2A13SMN1; SMN2ALDH1A1HPGDL3MBTL1
SCHEMBL3634645 0.77 CYP2A13 (0.41) CYP2A13SMN1; SMN2ALDH1A1HPGDCA12
SCHEMBL12422172 0.77 CYP2A13 (0.46) CYP2A13SMN1; SMN2ALDH1A1HPGDL3MBTL1
SCHEMBL3278198 0.77 CYP2A13 (0.41) CYP2A13SMN1; SMN2ALDH1A1HPGDL3MBTL1
SCHEMBL21827557 0.77 CYP2A13 (0.41) CYP2A13SMN1; SMN2ALDH1A1HPGDCA12
SCHEMBL12716769 0.77 CYP2A13 (0.46) CYP2A13SMN1; SMN2ALDH1A1HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018044808-A1 INHIBITORS OF DUAL LEUCINE ZIPER (DLK) KINASE FOR THE TREATMENT OF DISEASE BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM (US) 2018-03-08 WO disclosed